Neurones S.A.

Informe acción ENXTPA:NRO

Capitalización de mercado: €1.1b

Neurones Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Luc de Chammard

Chief Executive Officer (CEO)

€240.0k

Compensación total

Porcentaje del salario del CEO100.0%
Permanencia del CEO39.4yrs
Participación del CEO59.6%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva19.6yrs

Actualizaciones recientes de la dirección

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02
What We Learned About Neurones' (EPA:NRO) CEO Pay

Recent updates

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Apr 26
Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Dec 01
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

May 18
If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones' (EPA:NRO) Returns Have Hit A Wall

Feb 10
Neurones' (EPA:NRO) Returns Have Hit A Wall

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Oct 26
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Sep 22
Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Apr 28
Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Jan 25
Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Jan 06
Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Jul 20
Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

May 06
Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Mar 24
Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09
Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 16
The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Jan 25
Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Jan 11
What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Dec 28
Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Dec 15
Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02
What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Nov 17
Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Jun 30
Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Luc de Chammard en comparación con los beneficios de Neurones?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

€49m

Sep 30 2023n/an/a

€49m

Jun 30 2023n/an/a

€48m

Mar 31 2023n/an/a

€46m

Dec 31 2022€240k€240k

€44m

Sep 30 2022n/an/a

€43m

Jun 30 2022n/an/a

€41m

Mar 31 2022n/an/a

€40m

Dec 31 2021€220k€220k

€38m

Sep 30 2021n/an/a

€37m

Jun 30 2021n/an/a

€36m

Mar 31 2021n/an/a

€33m

Dec 31 2020€220k€220k

€31m

Sep 30 2020n/an/a

€30m

Jun 30 2020n/an/a

€28m

Mar 31 2020n/an/a

€30m

Dec 31 2019€220k€220k

€31m

Sep 30 2019n/an/a

€30m

Jun 30 2019n/an/a

€30m

Mar 31 2019n/an/a

€28m

Dec 31 2018€220k€220k

€26m

Sep 30 2018n/an/a

€26m

Jun 30 2018n/an/a

€26m

Mar 31 2018n/an/a

€27m

Dec 31 2017€200k€200k

€27m

Compensación vs. Mercado: La compensación total de Luc($USD255.65K) está por debajo de la media de empresas de tamaño similar en el mercado French ($USD1.46M).

Compensación vs. Ingresos: La compensación de Luc ha sido consistente con los resultados de la empresa en el último año.

CEO

Luc de Chammard (69 yo)

39.4yrs

Permanencia

€240,000

Compensación

Mr. Luc de Chammard serves as the Chairman, Chief Executive Officer and Chief Information Officer of Neurones S.A. and served as its Co-Chief Executive Officer. Mr. de Chammard has been a Director at Neuro...

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Luc de Chammard
Chairman39.4yrs€240.00k59.58%
€ 665.9m
Bertrand Ducurtil
COO, Executive VP24.9yrs€240.00k3.87%
€ 43.2m
Hervé Pichard
Director19.6yrs€5.00ksin datos
Jean-Louis Pacquement
Independent Director39.4yrs€5.00ksin datos
Marie-Françoise Jaubert
Independent Director12.9yrs€4.00ksin datos
Daphné de Chammard
Director7.9yrs€4.00ksin datos
Emmanuelle Canza
Employee Representative Director4.9yrssin datossin datos

19.6yrs

Permanencia media

68.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de NRO son experimentados ( 19.5 años antigüedad media).